Alpha Profiles · Company Profile

ABBOTT LABORATORIES

https://registry.alpha.ac/companies/abbott-laboratories

Entity: Public listing published
Primary listing: NYSE: ABT
Verification: Partially verified
Last reviewed: 2026-09-05T21:30:34.215281+00:00

Overview

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditi

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

5 public records

C. J. Scoggins

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: ABT executive roster sourceMay 3, 2026

John A. McCoy, Jr.

Vice President, Finance and Controller

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: ABT executive roster sourceMay 3, 2026

Philip P. Boudreau

Executive Vice President, Finance and Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: ABT executive roster sourceMay 3, 2026

R. B. Ford

Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: ABT executive roster sourceMay 3, 2026

Robert B. Ford

Chairman of the Board and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: ABT executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 5, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.